1 option
Biomedical translational research : technologies for improving healthcare / R. C. Sobti and Aastha Sobti.
- Format:
- Book
- Author/Creator:
- Sobti, R. C., author.
- Sobti, Aastha, author.
- Language:
- English
- Subjects (All):
- Biomedical engineering.
- Biomedical engineering--Handbooks, manuals, etc.
- Physical Description:
- 1 online resource (500 pages)
- Place of Publication:
- Springer Nature Singapore
- Singapore : Springer, [2022]
- Summary:
- This book, which is the first volume of Biomedical Translational Research, summarizes emerging technologies in healthcare. The book reviews the advancements in biomedical sciences in genomics, immunology, stem cell, tissue engineering, nanotechnology, computational and structural biology, biomedical engineering, and telemedicine biology. The book highlights the applications of artificial intelligence in the diagnosis of infectious diseases and examines the role of system biology approaches for understanding human complexity, variability, and its influence on health and diseases. It presents the applications of flow cytometry in monitoring the progression and treatment of disease. It covers emerging technologies in cancer research, including CRISPR-Cas9, NGS, and nanotechnology. This book is a useful source of information for clinical researchers, basic scientists, biomedical engineers, and computational biologists.
- Contents:
- Intro
- Preface
- Contents
- About the Editors
- 1: Introduction to Emerging Technologies in Biomedical Sciences
- 1.1 Introduction
- 1.2 Imaging Cells to Molecules in 3D
- 1.3 Genetic Engineering with Precision
- 1.4 Omics Technologies
- 1.5 Next-Generation Sequencing
- 1.6 Spectroscopy of Single-Molecule and Mixtures
- 1.7 Informatics and Simulations
- 1.8 Automation and Miniaturization of Experiments (Robotic Liquid Handling Systems and Microfluidics)
- 1.9 Microelectromechanical Systems in Biology (Bio-MEMS)
- 1.10 Personalized Medicine
- 1.11 Exosomes in Cancer Immunotherapy
- 1.12 Neuronal Tracing Techniques
- 1.13 Miniaturized Bioreactors
- 1.14 Transcranial Magnetic Stimulation (TMS)
- 1.15 Bionic Organism or Cyborg Cells
- 1.16 Conclusion
- References
- 2: Bioprospecting: Boon or Curse
- 2.1 United Nations Convention on Biological Diversity.
- 2.2 Virtues of Bioprospecting
- 2.3 Demons of Bioprospecting
- 2.4 Resolution to the Concerns
- 2.5 Conclusions and Future Prospects
- 3: Growing Need for Interdisciplinary Biomedical Research
- 3.1 Introduction
- 3.2 Interdisciplinary Research
- 3.2.1 Cardiovascular Health and Diseases
- 3.2.2 Studies on Pathogens
- 3.2.3 Schizophrenia
- 3.3 Increasing Urgency in Some Fields of Research
- 3.4 Why Do We Need Interdisciplinary Research?
- 3.5 Future Directions for Interdisciplinary Research
- 3.6 Concluding Remarks
- 4: Interplay Between Theory and Experiment: A Future Approach for Biomedical Research
- 4.1 History
- 4.2 Introduction
- 4.2.1 Cytochrome P450 (P450)
- 4.3 Experiment That Created Doubt
- 4.3.1 Site-Directed Mutagenesis
- 4.3.1.1 Ethylene Epoxidation by CPD 0 and CPD I
- 4.3.2 DFT and QM/MM Studies of Alkyl Sulfide
- 4.3.2.1 Sulfoxidation by Cpd 0 and Cpd I
- 4.3.2.2 Radical Clock Experiment.
- Rebound Controversy and Its Resolution by TSR Scenarios
- 4.3.2.3 Products Isotope Effect and TSR
- 4.3.2.4 Quantum Mechanical and Molecular Mechanical Application in Biomedical
- 4.4 Establishing and Testing Reaction Mechanisms
- 4.4.1 Lysozymes
- 4.4.2 Citrate Synthase
- 4.5 QM/MM Modeling of Drug Target Enzyme
- 4.5.1 Fatty-Acid Amide Hydrolase (FAAH)
- 4.5.2 Zn Enzymatic Drug Metabolism: Antibiotic Hydrolysis by Metallo-β-Lactamases Enzymes
- 4.6 Summary
- 5: Past, Present, and Future Perspective of Biomedical Innovation in India
- 5.1 Introduction
- 5.2 Background to Biomedical Innovation in India
- 5.3 Biomedical Innovation in India: Lessons Learned from the Past
- 5.4 Contemporary Advancements in Biomedical Innovation
- 5.5 Lessons Learnt from Pre-COVID Biomedical Innovation in India
- 5.6 ``Innovations´´ Stimulated by the COVID-19 Pandemic
- 5.7 Lessons from COVID-Related Innovations
- 5.8 Future Perspectives: The Way Forward
- 5.9 Conclusion
- 6: Systems Biology Approaches to Study Disease Comorbidities
- 6.1 Introduction
- 6.2 Systems Network Biology Perspective to Study Disease Co-occurrence
- 6.3 Analysis of Disease Co-occurrence Using Biological Networks
- 6.3.1 Using Protein-Protein Interaction to Study Diseases
- 6.3.2 Using Gene-Gene Interaction Networks to Study Diseases
- 6.3.3 Pathway Enrichment Analysis or Functional Enrichment Analysis
- 6.3.4 Disease-Gene Interaction
- 6.4 Identifying Critical Hub Proteins and Probable Therapeutic Targets
- 6.5 Concluding Remarks
- 7: Bioinformatics: The Interactome of Multidisciplinary Approaches
- 7.1 Introduction
- 7.2 Bioinformatics Databases
- 8: Role of Artificial Intelligence in Diagnosis of Infectious Diseases
- 8.1 Impact of Infectious Diseases
- 8.2 New Technologies for Infectious Diseases.
- 8.3 History of Artificial Intelligence
- Box 8.1 Definitions
- 8.4 Clinical Microbiology and Artificial Intelligence
- 8.4.1 Microscopy Image Analysis
- 8.4.2 Digital Plate Reading (DPR)
- 8.4.3 Matrix-Assisted Laser Desorption Ionization Time of Flight Mass Spectrometry (MALDITOF MS)
- 8.4.4 Antimicrobial Resistance Prediction by Whole Genome Sequencing (WGS)
- 8.5 AI in Infection Prevention and Control (IPC)
- 8.5.1 Surveillance of Healthcare Associated Infections (HAI)
- 8.5.2 Improved Laboratory Diagnosis to Facilitate IPC Interventions
- 8.5.3 Hand Hygiene
- 8.6 Disease Surveillance and Epidemiology
- 8.7 Role of Artificial Intelligence in COVID-19 Pandemic
- 8.7.1 Predicting and Monitoring the Infection
- 8.7.2 Early Detection and Diagnosis of Infection
- 8.7.3 Monitoring Treatment
- 8.7.4 Surveillance
- 8.7.5 Real-Time Spread Tracking and Contact Tracing
- 8.7.6 Projection of Cases and Mortality
- 8.7.7 Creating Chatbots
- 8.7.8 Treatment Through AI
- 8.8 Summary, Conclusion, and Future Prospects
- 9: DNA Digital Data Storage: Breakthroughs in Biomedical Research
- 9.1 Introduction
- 9.2 Why Scientist Selected DNA for Data Storage System
- 9.3 How Data Can Be Stored in DNA
- 9.4 Related Work
- 9.5 Conclusion
- 10: Biomedical Applications Cloud-Based IoT
- 10.1 Introduction
- 10.2 Related Work
- 10.3 Internet of Things Model
- 10.3.1 Internet
- 10.3.2 Processing
- 10.3.3 Things
- 10.3.4 Hierarchical Architecture
- 10.3.4.1 Physical Layer
- 10.3.4.2 Network Layer
- 10.3.4.3 Middleware Layer
- 10.3.4.4 Application Layer
- 10.3.5 Cloud Model
- 10.3.5.1 Software as a Service (SaaS)
- 10.3.5.2 Platform as a Service (Paas)
- 10.3.5.3 Infrastructure as a Service (IaaS)
- 10.4 Integrated Cloud with IoT (Cloud IoT)
- 10.4.1 Features of Integrated Cloud IoT
- 10.4.1.1 Storage Space.
- 10.4.1.2 Computing Power
- 10.4.1.3 Communication
- 10.4.1.4 New Security Model
- 10.4.2 Cloud IoT Applications
- 10.4.2.1 Smart Health Care
- 10.4.2.2 Internet of Robotic Things (IoRT)
- 10.4.2.3 Signal Processing
- 10.4.2.4 Smart Medical Devices
- 10.4.2.5 Wearable IoT (WIoT)
- 10.4.3 Open Challenges in Integrated Cloud IoT
- 10.4.3.1 Privacy and Security
- 10.4.3.2 Need for Standard Architecture of Protocol
- 10.4.3.3 Efficient Power Consumption
- 10.4.3.4 Limited Bandwidth
- 10.4.3.5 Delayed Services
- 10.5 Conclusion
- 11: Next-Generation Sequencing in Cancer Research
- 11.1 Introduction
- 11.2 Overview of the Experimental Approach for DNA/RNA Sequencing Platforms
- 11.2.1 Whole-Exome Sequencing (WES)
- 11.2.2 Whole-Genome Sequencing (WGS)
- 11.2.3 Targeted Panel Sequencing
- 11.2.4 RNA Sequencing (RNA-seq)
- 11.2.5 Single-Cell DNA/RNA Sequencing
- 11.3 NGS Utility in Clinical Oncology in Solid Tumors
- 11.4 NGS Utility in Clinical Oncology in Liquid Biopsies
- 11.5 Challenges of NGS Technologies
- 11.6 Concluding Remarks
- 12: CRISPR: Genome Editing and Beyond
- 12.1 Introduction
- 12.2 Discovery
- 12.3 Classification
- 12.3.1 Class 1
- 12.3.2 Class 2
- 12.4 Molecular Mechanism
- 12.4.1 Adaptation
- 12.4.2 crRNA Biogenesis
- 12.4.3 Interference
- 12.5 Applications
- 12.5.1 Genome Editing
- 12.5.2 Transcriptional Regulation
- 12.5.3 Post-transcriptional Engineering
- 12.5.4 Programmable DNA and RNA Imaging
- 12.5.5 Nucleic Acid Detection and Diagnostics
- 12.6 Future Prospects
- 13: Omics in Tuberculosis Diagnosis: Today and Tomorrow
- 13.1 Introduction
- 13.2 Genomics in TB Diagnosis
- 13.2.1 TB Diagnostic Tests Available in the Clinics Based on Genomics
- 13.2.2 Recent Advances and Future Prospective in Genomics for Tuberculosis Diagnosis.
- 13.3 Proteomics in TB Diagnosis
- 13.3.1 TB Diagnostic Tests Available in the Clinics Based on Proteomics
- 13.3.2 Recent Advances and Future Prospective in Proteomics for Tuberculosis Diagnosis
- 13.3.2.1 Pathogen Proteomic Biomarkers as Candidates for TB Diagnosis
- 13.3.2.2 Host Proteomic Biomarkers Candidate for TB Diagnosis
- 13.4 Other Omics Technologies for Potential Use for TB Diagnosis
- 13.5 Concluding Remarks
- 14: Advances in Proteomics Approaches and Chronic Kidney Disease
- 14.1 Introduction
- 14.2 Historical Background
- 14.3 Proteomics Advancements and Chronic Kidney Disease
- 14.3.1 Advancements in Proteomics Analysis
- 14.3.2 Chronic Kidney Disease and Proteomics
- 14.4 Conclusion
- 15: 3D Bioprinting of Tissues and Organs: A New Paradigm in Regenerative Medicine and Biomedical Engineering
- 15.1 Introduction
- 15.2 History
- 15.3 3D Bioprinting Procedure
- 15.4 Bioinks
- 15.5 Hydrogels for Bioprinting
- 15.6 Methods of 3D Bioprinting
- 15.6.1 Inkjet-Based Bioprinting
- 15.6.2 Laser-Based Bioprinting
- 15.6.3 Extrusion Bioprinting/Direct Writing
- 15.6.4 Bioplotting
- 15.6.5 Fused-Deposition Modeling (FDM)
- 15.6.6 Stereolithography (SL)
- 15.7 Applications of 3D Bioprinting
- 15.7.1 Tissues and Organs Printing
- 15.7.2 Customized Implants and Prostheses
- 15.7.3 Anatomical Models
- 15.7.4 3D-Printed Dosage Forms and Drug Delivery Devices
- 15.7.5 Unique Dosage Forms
- 15.7.6 Drug Testing
- 15.7.7 Other Applications with Some Challenges
- 15.8 Tissue Engineering and Regenerative Medicine
- 15.8.1 Components of Tissue Engineering
- 15.8.1.1 Scaffold
- 15.8.1.2 Cells
- 15.8.1.3 Growth Factors
- 15.8.2 Limitations
- 15.8.3 3D Bioprinting and Tissue Engineering
- 15.8.4 Tissue Engineering of Different Organs
- 15.8.4.1 Cardiac
- 15.8.4.2 Liver.
- 15.8.4.3 Cartilage Bone.
- Notes:
- Description based on print version record.
- Other Format:
- Print version: Sobti, R. C. Biomedical Translational Research
- ISBN:
- 981-16-4344-X
- 981-16-4345-8
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.